Stay updated with breaking news from Designation Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In May 2022, the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) announced the launch of a new program for expediting the development of new treatment options for rare diseases—Accelerating Rare disease Cures (ARC) Program.1 The FDA considers a disease that affects fewer than 200,000 people in the U.S. a rare disease, and estimates that more than 30…
If we as leaders, directors, investors and simply human beings don’t see ourselves as stewards of the future, we are letting down our employees, our customers and our suppliers.
The FDA will provide the Genio system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the United States.
Obama administration is going to eliminate it all together. explain what the program was and what this means. >> the program was a post-9/11 program and it was a country-based designation program that men of a certain age would be given sort of higher review. it wasn't a ban. it was just a higher review. over time when the obama administration came into place, i should say all of those countries were muslim countries except for i think we put north korea in there for good measure. so when the obama administration came in, it wasn't that they weren't tracking people or people who might be on li...